Cognitive Therapy for Suicidal Older Men

Status Completed

Clinical Trial Summary

The primary aim of the proposed study is to compare the efficacy of cognitive therapy (CT) with the efficacy of an enhanced usual care (EUC) intervention for reducing the rate of suicide ideation (SI) and the severity of depression and hopelessness among older men. The investigators expect that suicidal older men randomly assigned to the CT intervention condition will have a lower rate of SI during the follow-up period than participants assigned to the control condition.

Clinical Trial Description

Older adult males have the highest suicide rate of any age group in the U.S. However, most research concerning treatments for suicide ideation and behavior has focused on adolescents and young adults. Very few treatments have been developed to reduce suicide ideation and behavior in men aged 50 and above. This study will assess the effectiveness of specialized cognitive therapy versus enhanced usual care in treating older men with suicide ideation.

Participants in this five-year study will be randomly assigned to receive either cognitive therapy or enhanced usual care. Participants will be identified within the VA Medical Center and the University of Pennsylvania Health System (UPHS) as having experienced suicide ideation in the past month. Cognitive therapy will be provided by Ph.D.-level therapists and will be geared specifically toward older men with suicidal tendencies. The enhanced usual care condition will consist of the usual care that individuals receive for suicide prevention, plus assessment and referral services provided by independent evaluators and study case managers. In addition, patients in the enhanced usual care condition will receive weekly telephone calls from the study therapists. These phone calls will be approximately 15-30 minutes in duration and their purpose will be to ensure patient safety and to provide some support. All participants will be assessed pre-treatment to attain baseline measures of suicide ideation, hopelessness, and depression. Study visits will occur at baseline and Months 1, 3, 6, 9, and 12 to assess suicide ideation. Self-report and clinician-administered measures will be used to assess participants' progress. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01535482
Study type	Interventional
Source	University of Pennsylvania
Contact
Status	Completed
Phase	N/A
Start date	September 2011
Completion date	April 6, 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03185026` - Psychoeducation for Suicidal Behavior	N/A
Recruiting	`NCT05609487` - Evaluation of the Safety Plan to Prevent Suicidal Reiteration	N/A
Recruiting	`NCT06322199` - Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
Completed	`NCT03134885` - Evaluation of a Regional Post-discharge Monitoring System for Suicide Attempters
Completed	`NCT01118208` - Blister Packaging Medication to Increase Treatment Adherence and Clinical Response	N/A
Completed	`NCT01360736` - A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans - Study 2 (SAFEMIL)	N/A
Completed	`NCT05580757` - Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
Not yet recruiting	`NCT05427734` - Treating Drivers of Suicide Using Jaspr Health	N/A
Recruiting	`NCT05537376` - A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness	N/A
Completed	`NCT03227991` - Safety Planning Intervention to Reduce Short Term Risk	N/A
Recruiting	`NCT04962373` - Brief Admission for Adolescents Who Self-harm
Completed	`NCT02985047` - Brief Admission Skane: Replacing General Admission for Individuals With Self-harm and Acute Risk of Suicide	N/A
Enrolling by invitation	`NCT06060535` - Implementation of Suicide Risk Models in Health Systems	N/A
Recruiting	`NCT04994873` - Skills to Enhance Positivity in Suicidal Youth	N/A
Recruiting	`NCT04592809` - Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents	Phase 3
Completed	`NCT01176929` - Randomized Controlled and Prospective Trial of a Cohort of People Who Made a Suicide Attempt	N/A
Completed	`NCT00558805` - Family Intervention for Suicidal Youth: Emergency Care	Phase 2
Recruiting	`NCT05390918` - Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior	N/A
Recruiting	`NCT04746261` - A Randomized Clinical Study of "Attempted Suicide Short Intervention Program" in Swedish Healthcare - ASSIP	N/A
Recruiting	`NCT05437588` - Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.